EUVIMEDEUVIMED entdecken
Crossref

Surgical treatment of invasive pulmonary fungal infections in immunocompromised pediatric patients: Aspergillus spp. and other emerging fungi

Sergio López-Fernández, José Andrés Molino, Pere Soler-Palacín, Natalia Mendoza-Palomar, Maria Luz Uria Oficialdegui, Marta Martos Rodríguez, Manuel López, Gabriela Guillén

Pediatric Surgery International · 2024

DOI: 10.1007/s00383-024-05851-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Surgery International, 2024. Verfasst von Sergio López-Fernández und 7 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Surgical Oncology Unit, Department of Pediatric Surgery, Vall d'Hebron University Hospital, Passeig de la Vall d'Hebron 119, 08035, Barcelo…. Hauptthemen laut MEDLINE: Immunocompromised Host. Die Arbeit nennt 31 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Invasive Pulmonary Fungal Infections (IPFIs) represent a diagnostic and therapeutic challenge. The exact role of surgery is not well defined. This study analyzes our experience with surgical treatment of IPFI in immunocompromised pediatric patients and, secondarily, compares IPFI caused by Aspergillus spp. with other fungal infections. METHODS: This is a retrospective review (2000-2019) of patients with IPFI surgically treated at our pediatric institution. Statistical analysis was used to compare data between Aspergillus spp. and non-Aspergillus IPFI. RESULTS: Twenty-five patients (64% female) underwent 29 lung resections. Median age at surgery was 7.19 years (1.63-19.14). The most frequent underlying condition (64%) was acute leukemia. Surgical indications included persistence or worsening of symptoms and pathological image findings (52%) or asymptomatic suspicious lesions in patients scheduled for intensive cytotoxic treatments or hematopoietic stem cell transplantation (48%). All patients underwent atypical lung resections, except one lobectomy. Aspergillus spp. was the most frequently isolated pathogen (68%). Follow-up was 4.07 years (0.07-18.07). Surgery-related mortality was 0%, but 4 patients died in the 100 days following surgery (2 due to disseminated fungal infection); the remaining 21 did not show signs of IPFI recurrence. Non-specific consolidations on CT scan were more frequent in non-Aspergillus IPFI (p < 0.05). CONCLUSION: Surgical treatment of IPFI should be considered as a part of the treatment in selected pediatric immunocompromised patients, and it may have both diagnostic and therapeutic advantages over non-surgical management. When there is clinical suspicion of IPFI but CT scan shows unspecific alterations, the possibility of a non-Aspergillus IPFI should be considered.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immunocompromised HostHumansChildFemaleRetrospective StudiesMaleAdolescentChild, PreschoolInfantLung Diseases, FungalInvasive Fungal InfectionsAspergillusYoung AdultPneumonectomy

Stichwörter der Autor:innen

Hematologic malignanciesImmunocompromisedPediatricPulmonary fungal infectionSurgery

Autor:innen und Institutionen

  • Pediatric Surgical Oncology Unit, Department of Pediatric Surgery, Vall d'Hebron University Hospital, Passeig de la Vall d'Hebron 119, 08035, Barcelona, Spain. sergio.lopez@vallhebron.cat.
  • Pediatric Surgical Oncology Unit, Department of Pediatric Surgery, Vall d'Hebron University Hospital, Passeig de la Vall d'Hebron 119, 08035, Barcelona, Spain.
  • Pediatric Infectious Diseases and Immunodeficiencies Unit, Vall d'Hebron University Hospital, Vall d'Hebron Research Institute, Barcelona, Spain.
  • Department of Pediatric Oncology and Hematology, Vall d'Hebron University Hospital, Barcelona, Spain.

Zitieren

APA

López-Fernández, S., Molino, J. A., Soler-Palacín, P., Mendoza-Palomar, N., Uria Oficialdegui, M. L., Martos Rodríguez, M., López, M., & Guillén, G. (2024). Surgical treatment of invasive pulmonary fungal infections in immunocompromised pediatric patients: Aspergillus spp. and other emerging fungi. Pediatric Surgery International. https://doi.org/10.1007/s00383-024-05851-5

Vancouver

López-Fernández S, Molino JA, Soler-Palacín P, Mendoza-Palomar N, Uria Oficialdegui ML, Martos Rodríguez M, et al. Surgical treatment of invasive pulmonary fungal infections in immunocompromised pediatric patients: Aspergillus spp. and other emerging fungi. Pediatric Surgery International. 2024. doi:10.1007/s00383-024-05851-5

BibTeX
@article{LpezFernndez2024,
  author = {López-Fernández, Sergio and Molino, José Andrés and Soler-Palacín, Pere and Mendoza-Palomar, Natalia and Uria Oficialdegui, Maria Luz and Martos Rodríguez, Marta and López, Manuel and Guillén, Gabriela},
  title = {Surgical treatment of invasive pulmonary fungal infections in immunocompromised pediatric patients: Aspergillus spp. and other emerging fungi},
  journal = {Pediatric Surgery International},
  year = {2024},
  doi = {10.1007/s00383-024-05851-5}
}
Kostenlos starten →